@article{4fd3c07041154441bfde9a924498c076,
title = "Early experience with meropenem- vaborbactam for treatment of carbapenem-resistant enterobacteriaceae infections",
abstract = "Twenty patients with carbapenem-resistant Enterobacteriaceae infections were treated with meropenem-vaborbactam. Thirtyday clinical success and survival rates were 65% (13/20) and 90% (18/20), respectively. Thirty-five percent of patients had microbiologic failures within 90 days. One patient developed a recurrent infection due to meropenem-vaborbactam- nonsusceptible, ompK36 porin mutant Klebsiella pneumoniae.",
author = "Shields, {Ryan K.} and McCreary, {Erin K.} and Marini, {Rachel V.} and Kline, {Ellen G.} and Jones, {Chelsea E.} and Binghua Hao and Liang Chen and Kreiswirth, {Barry N.} and Yohei Doi and Clancy, {Cornelius J.} and Nguyen, {M. Hong}",
note = "Funding Information: Financial support. This work was supported by an investigator-initiated grant from Melinta Pharmaceuticals. The following authors are supported by the National Institutes of Health (NIH): R. K. S. (grant numbers K08AI114883 and R03AI144636); B. N. K. (grant numbers R01AI090155, R2AI135250, and U19AI142731); Y. D. (grant numbers R01AI104895 and R21AI135522); C. J. C (grant numbers R21AI126157, R21AI142049, and R21AI144390); M. H. N. (grant number R21AI128338). Publisher Copyright: {\textcopyright} The Author(s) 2019.",
year = "2020",
month = aug,
day = "1",
doi = "10.1093/cid/ciz1131",
language = "English",
volume = "71",
pages = "667--671",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "3",
}